Hawthorne Health and RxE2 Partner to Expand Patient Access in Clinical Trials
WALNUT CREEK, CA. & FARGO, ND, January 30, 2025 Hawthorne Health, the leader in community trial delivery, and RxE2, a pioneer in pharmacist-led clinical trial
Hawthorne Health and RxE2 have announced a strategic partnership to transform community-based clinical trial delivery.
WALNUT CREEK, CA. & FARGO, ND, January 30, 2025 Hawthorne Health, the leader in community trial delivery, and RxE2, a pioneer in pharmacist-led clinical trial
New CEO and board appointees from Labcorp, CVS Health and Northpond Ventures join to fuel company’s rapid growth and leadership position within the clinical trials market … Read More
Collaboration Aims to Improve Patient Experience, Accessibility and Efficiency in Decentralized Clinical Trials … Read More
Hawthorne Health (HH) partnered with sponsors conducting clinical trials for cardiovascular disease (CVD), specifically targeting BTK (below-the-knee) conditions, like Chronic Limb Ischemia. … Read More
Clinical research can be an unheralded, even misunderstood field, but we have two important perspectives that demonstrate just how impactful clinical trials are … Read More
A truly integrated, patient-centric delivery model that includes research as a foundational component will require more than new technologies … Read More
Let’s discuss how Hawthorne Health can take your clinical trial to completion and approval with access and accuracy